---
title: "Sudarshan Pharma Industries Ltd (543828) — Share Price, Financials & Analysis"
symbol: "543828"
company: "Sudarshan Pharma Industries Ltd"
canonical: "https://tapetide.com/stocks/543828"
isin: "INE00TV01023"
nse_symbol: "SUDARSHANPHARMAINDUSTRIESLTD"
bse_code: "543828"
sector: "Chemicals"
industry: "Dyes & Pigments"
market_cap_cr: 985.9
generated_at: "2026-09-13T18:37:37.411Z"
---

# Sudarshan Pharma Industries Ltd (543828)

Canonical page: https://tapetide.com/stocks/543828

## Company

- **NSE Symbol:** SUDARSHANPHARMAINDUSTRIESLTD
- **BSE Code:** 543828
- **ISIN:** INE00TV01023
- **Sector:** Chemicals
- **Industry:** Dyes & Pigments
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2023-03-22
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** sudarshanpharma.com

## About

Incorporated in 2008, Sudarshan Pharma Industries Ltd manufactures API and Pharmaceutical Items. It also trades in Chemicals and Solvents[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:37:38.444628Z.

- **Market Cap:** ₹985.9 Cr
- **Classification:** SME
- **P/E (reported):** 39.5
- **EPS (TTM):** ₹1.03
- **EPS (reported):** ₹4.76
- **Book Value:** ₹6.82
- **Price to Book:** 5.79
- **Dividend Yield:** 0.76%
- **ROE:** 12.13%
- **ROCE:** 26.21%
- **Debt to Equity:** 1.84
- **Revenue (yearly):** ₹703.06 Cr
- **Net Income:** ₹23.22 Cr
- **EBITDA:** ₹51.32 Cr
- **52-Week High:** ₹42.79
- **52-Week Low:** ₹18.5
- **RSI (14):** 52.6

## Tapetide Score

- **Score:** 42 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 19.7 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 24.8 | 9% |
| growth | 91.11 | 9% |
| momentum | 89.91 | 12% |
| ownership | 33.7 | 24% |
| quality | 35.8 | 22% |
| valuation | 21.79 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is expected to give good quarter
- Company has delivered good profit growth of 54.2% CAGR over last 5 years
- Promoter holding has increased by 1.54% over last quarter.
- Company's working capital requirements have reduced from 44.1 days to 17.1 days

### Weaknesses

- Stock is trading at 6.12 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 486.02% | 222.33% | — |
| ebitda margin growth | -29.63% | -13.76% | 32.29% | 126.73% |
| net income growth | -50.88% | 45.13% | 48% | 54% |
| revenue growth | -21.96% | 38.51% | 15% | 29% |
| roce | -32.33% | 32.57% | 100.54% | 22.69% |
| roe | -50.75% | 18.34% | 9.78% | 2.45% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 99.2 | 128.58 | 115.66 | 161.59 | 145.26 | 168.87 | 168.01 | 220.92 | 174.42 |
| Expenses | 97.12 | 115.53 | 107.69 | 145.66 | 134.22 | 159.66 | 157.14 | 200.72 | 158.52 |
| Operating Profit | 2.08 | 13.05 | 7.97 | 15.93 | 11.04 | 9.21 | 10.87 | 20.2 | 15.9 |
| OPM % | 2.1 | 10.15 | 6.89 | 9.86 | 7.6 | 5.45 | 6.47 | 9.14 | 9.12 |
| Other Income | 0.98 | -0.85 | 0.51 | -0.81 | 1.21 | 1.86 | 1.52 | 4.13 | 1.22 |
| Interest | 3.94 | 3.7 | 4 | 4.4 | 5.96 | 5.94 | 6.28 | 7.53 | 8.21 |
| Depreciation | 0.67 | 0.67 | 0.63 | 0.83 | 0.88 | 0.9 | 0.91 | 1.09 | 1.41 |
| Profit before tax | -1.55 | 7.83 | 3.85 | 9.89 | 5.41 | 4.23 | 5.2 | 15.71 | 7.5 |
| Tax % | -21.94 | 24.9 | 24.94 | 25.08 | 26.8 | 8.51 | 20.19 | 27.43 | 25.33 |
| Net Profit | -1.21 | 5.88 | 2.88 | 7.41 | 3.96 | 3.87 | 4.15 | 11.4 | 5.61 |
| EPS in Rs | -0.05 | 0.24 | 0.12 | 0.31 | 0.17 | 0.17 | 0.18 | 0.45 | 0.23 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 148 | 193 | 357 | 461 | 464 | 505 | 703 | 732 |
| Expenses | 143 | 186 | 346 | 446 | 441 | 465 | 652 | 676 |
| Operating Profit | 5 | 7 | 11 | 15 | 23 | 40 | 51 | 56 |
| OPM % | 3.2 | 3.7 | 3.1 | 3.2 | 4.9 | 8 | 7 | 8 |
| Other Income | 0 | 0 | 0 | 1 | 3 | 0 | 9 | 9 |
| Interest | 3 | 3 | 3 | 5 | 9 | 16 | 26 | 28 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 2 | 4 | 4 |
| Profit before tax | 2 | 4 | 7 | 9 | 15 | 22 | 31 | 33 |
| Tax % | 26 | 25 | 26 | 26 | 25 | 26 | 23 | — |
| Net Profit | 1 | 3 | 5 | 7 | 11 | 16 | 23 | 25 |
| EPS in Rs | 0.13 | 0.28 | 0.54 | 0.29 | 0.48 | 0.66 | 0.97 | 1.03 |
| Dividend Payout % | 0 | 0 | 0 | 10 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 10 | 10 | 10 | 24 | 24 | 24 | 24 |
| Reserves | 10 | 13 | 20 | 77 | 88 | 107 | 131 |
| Borrowings | 21 | 30 | 31 | 34 | 105 | 171 | 285 |
| Other Liabilities | 18 | 47 | 77 | 97 | 67 | 100 | 202 |
| Total Liabilities | 58 | 99 | 138 | 232 | 283 | 402 | 642 |
| Fixed Assets | 6 | 6 | 6 | 20 | 26 | 24 | 104 |
| CWIP | 0 | 0 | 1 | 0 | 2 | 6 | 3 |
| Investments | 0 | 0 | 0 | 12 | 14 | 30 | 0 |
| Other Assets | 53 | 93 | 131 | 200 | 242 | 342 | 534 |
| Total Assets | 58 | 99 | 138 | 232 | 283 | 402 | 642 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 1 | 3 | -4 | -29 | 6 | 35 | -2 |
| Cash from Investing Activity | -3 | -1 | -1 | -26 | -5 | -20 | -78 |
| Cash from Financing Activity | 0 | -1 | 4 | 66 | -12 | -14 | 79 |
| Net Cash Flow | -2 | 0 | -1 | 11 | -12 | 0 | -1 |
| Free Cash Flow | -4 | 1 | -5 | -43 | 2 | 30 | -51 |
| CFO/OP | 20 | 50 | -19 | -179 | 36 | 96 | 7 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 66 | 114 | 75 | 64 | 96 | 116 | 121 |
| Inventory Days | 46 | 49 | 51 | 63 | 74 | 117 | 129 |
| Days Payable | 40 | 91 | 80 | 78 | 49 | 76 | 111 |
| Cash Conversion Cycle | 72 | 72 | 46 | 50 | 122 | 156 | 139 |
| Working Capital Days | 35 | 29 | 27 | 54 | 62 | 53 | 17 |
| ROCE % | — | 15 | 19 | 15 | 14 | 16 | 15 |

## Shareholding Pattern

### Quarterly

| Category | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 57.39% | 57.39% | 57.39% | 57.39% | 57.39% | 57.39% | 57.39% | 57.39% | 57.39% | 58.93% |
| FIIs | 3.58% | 1.4% | 1.4% | 13.07% | 18.45% | 19.48% | 20.79% | 19.78% | 19.95% | 19.38% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% |
| Public | 20.35% | 27.04% | 23.61% | 23.2% | 18.18% | 17.14% | 16.3% | 16.88% | 16.41% | 16.37% |
| Others | 18.68% | 14.16% | 17.59% | 6.33% | 5.98% | 5.94% | 5.46% | 5.9% | 6.2% | 5.27% |
| No. of Shareholders | 2785 | 983 | 913 | 787 | 1212 | 1327 | 1383 | 1407 | 1346 | 1231 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 10 / 6 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 39.78 | Sell |
| EMA (10) | 39.77 | Sell |
| SMA (20) | 39.14 | Buy |
| EMA (20) | 39.19 | Buy |
| SMA (50) | 38.69 | Buy |
| EMA (50) | 38.12 | Buy |
| SMA (100) | 36.3 | Buy |
| EMA (100) | 36.05 | Buy |
| SMA (200) | 30.7 | Buy |
| EMA (200) | 33.36 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 52.51 | Neutral |
| MACD (12,26,9) | 0.71 | Buy |
| Stochastic (14,3,3) | 45.36 | Neutral |
| ADX (14) | 15.57 | Neutral |
| Williams %R (14) | -65.73 | Neutral |
| ATR (14) | 1.96 | High Volatility |
| ROC (12) | -1.72 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 58.25 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53DBCFF8_01DE_4651_BBD7_A8697E4C40D8_195739.pdf) |
| 2026-09-09 | [Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=BF2192D7_834B_4CFE_967C_254ADF5D97B0_195928.pdf) |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Acquisition](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a47a13c-6520-43c4-b371-9852bf1ddb50.pdf) |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9821779a-db2a-4046-a09e-29530774f0ad.pdf) |
| 2026-08-29 | [Annual General Meeting Of The Company On Tuesday 22/September/2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2b1a239-56d1-4516-b50a-df779f2d0f33.pdf) |
| 2026-08-29 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b2d79e9-da59-46bc-89cb-4de5d12f83eb.pdf) |
| 2026-08-29 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fffda120-2093-4958-8948-3343030bb130.pdf) |
| 2026-08-26 | [Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09AFA448_8347_4D30_A642_9E2BD1D8DFA5_193109.pdf) |
| 2026-08-22 | [Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92CE3EFC_74FE_49A5_9949_41D22408AF63_101300.pdf) |
| 2026-08-19 | [Announcement under Regulation 30 (LODR)-Allotment](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2db54aa-d652-4c5d-80ea-f494786d3a98.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-18 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81b332f3-f295-4246-a4ba-a9e755039a24.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a882519a-06dc-48f5-86e6-4bcbd9c3f6a5.pdf) |
| 2026-05-15 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6095ce0-4e2f-4285-a06b-77f4feca56ab.pdf) |
| 2026-01-31 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce2d7f65-c83d-4f18-bee6-253173548ac7.pdf) |
| 2025-08-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5050e6a7-b78f-49c1-8ffc-101f9d8b60d3.pdf) |
| 2025-05-02 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8af6d6e7-e19a-45bf-a54a-5991aefabfd9.pdf) |
| 2025-01-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1bb3beb8-fdad-454d-acdf-edc6a3c22cb7.pdf) |
| 2024-07-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=727f5718-53d2-4ecd-9e55-7cb43ea08164.pdf) |
| 2024-01-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=426d1db4-efd6-4572-8c9d-58c6f7dede31.pdf) |
| 2023-09-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75ee4e10-02dd-4adf-a562-4983afc7f3b4.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Financial Results For The Quarter Ended 30/06/2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7bebe769-bde7-4707-9ef6-e830ae31df91.pdf) |
| 2026-04-30 | [Audited Financial Results For The Financial Year Ended 31-03-2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b841a10-c914-4855-a86e-180e9492748f.pdf) |
| 2026-01-28 | [Financial Results For The Quarter And Nine Months Ended 31-12-2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d1b1c32-0493-4f65-a946-25cb75fa9d92.pdf) |
| 2025-10-18 | [Financial Results For The Quarter And Half Year Ended 30-Sep-2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d606e337-b15a-42e4-8dcb-954641ed2c05.pdf) |
| 2025-08-14 | [Financial Results For The Quarter 30-06-2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a7b610b-348a-4773-aedd-8c7ddd7222ae.pdf) |
| 2025-04-24 | [Financial Results For The Financial Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=397b1263-d065-4c49-850f-b20ee41b4221.pdf) |
| 2024-10-31 | [Financial Results For The Half Year Ended 30Th September 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7fd55aa7-d0a9-44e5-9605-0b5ac90fa4a9.pdf) |
| 2024-05-27 | [FINANCIAL RESULT FOR THE HALF YEAR AND FINANCIAL YEAR ENDED MARCH 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28fc7f2e-41a5-40de-b65e-096eeb808c87.pdf) |
| 2023-11-10 | [Regulation 33 Of SEBI (Listing Obligations & Disclosure Requirements), 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6bb344b-fd42-4184-ad4a-660dc73c84b1.pdf) |
| 2023-05-26 | [Outcome Of The Meeting Of Board Of Directors Of The Company Held On May 26, 2023.<BR> <BR>](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=483ca7a2-9428-4b99-ba36-8a658711ee76.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Informs BSE no price-sensitive information; price movement due to market. | [Clarification On Price Movement - Company Reply 9 Feb - Informs BSE no price-sensitive information; price movement due to market.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5bdd2114-f2f3-490a-817b-7e2ec12c4e1c.pdf) |
| 8h - Board meeting on 30 April 2026 to approve audited Q4 and FY2026 standalone and consolidated results. | [Board Meeting Intimation for Meeting Scheduled On Thursday, April 30, 2026 8h - Board meeting on 30 April 2026 to approve audited Q4 and FY2026 standalone and consolidated results.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4e6049e2-d035-429a-9843-82fb0cfad9b2.pdf) |
| 8 May - Sachin Mehta resigned as CFO effective 1 May 2026, but continues as Joint Managing Director. | [Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) 8 May - Sachin Mehta resigned as CFO effective 1 May 2026, but continues as Joint Managing Director.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0d1d9b17-a3aa-4975-a8a5-e56b2a74e900.pdf) |
| 6 Apr - Copy of certificates under Regulation 74(5) of SEBI (Depository And Participants) Regulations, 2018 received from Kfin Technologies Limited for the quarter ended 31/March/2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Copy of certificates under Regulation 74(5) of SEBI (Depository And Participants) Regulations, 2018 received from Kfin Technologies Limited for the quarter ended 31/March/2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d62befad-1b18-421c-ae10-71d75175aba6.pdf) |
| 5 Jan - Certificate under Reg 74(5) for quarter ended Dec 31, 2025 confirming demat substitution and cancellation of mutilated certificates. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 5 Jan - Certificate under Reg 74(5) for quarter ended Dec 31, 2025 confirming demat substitution and cancellation of mutilated certificates.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/809dbdf8-b534-4835-9b35-ea152ea70b7e.pdf) |
| 4 May - Newspaper advertisement for the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended 31-03-2026 published in (i) Mumbai Lakshdeep (Marathi) and … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 4 May - Newspaper advertisement for the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended 31-03-2026 published in (i) Mumbai Lakshdeep (Marathi) and …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/20a4e6af-dc31-4904-a609-0a9665b61f9f.pdf) |
| 4 May - Newspaper advertisement for the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended 31-03-2026 published in (i) Mumbai Lakshdeep (Marathi) and … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 4 May - Newspaper advertisement for the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended 31-03-2026 published in (i) Mumbai Lakshdeep (Marathi) and …](https://www.bseindia.com/xml-data/corpfiling/AttachLive/20a4e6af-dc31-4904-a609-0a9665b61f9f.pdf) |
| 30 Apr - Sudarshan Pharma appoints two directors and a CFO effective 1 May 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 30 Apr - Sudarshan Pharma appoints two directors and a CFO effective 1 May 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/44ec522c-9c15-4f0c-b239-b01885cb9914.pdf) |
| 30 Apr - Sudarshan Pharma appoints two directors and a CFO effective 1 May 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 30 Apr - Sudarshan Pharma appoints two directors and a CFO effective 1 May 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/44ec522c-9c15-4f0c-b239-b01885cb9914.pdf) |
| 30 Apr - Board approved FY26 audited standalone and consolidated results on 30 Apr 2026; standalone PAT Rs2,198.16 lakh. | [Audited Financial Results For The Financial Year Ended 31-03-2026 30 Apr - Board approved FY26 audited standalone and consolidated results on 30 Apr 2026; standalone PAT Rs2,198.16 lakh.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8b841a10-c914-4855-a86e-180e9492748f.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2023 | [Concall - Sep 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/75ee4e10-02dd-4adf-a562-4983afc7f3b4.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f6095ce0-4e2f-4285-a06b-77f4feca56ab.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/f6095ce0-4e2f-4285-a06b-77f4feca56ab.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8af6d6e7-e19a-45bf-a54a-5991aefabfd9.pdf) |
| Jul 2024 | [Concall - Jul 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/727f5718-53d2-4ecd-9e55-7cb43ea08164.pdf) |
| Jan 2026 | [Concall - Jan 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ce2d7f65-c83d-4f18-bee6-253173548ac7.pdf) |
| Jan 2025 | [Concall - Jan 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1bb3beb8-fdad-454d-acdf-edc6a3c22cb7.pdf) |
| Jan 2024 | [Concall - Jan 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/426d1db4-efd6-4572-8c9d-58c6f7dede31.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5050e6a7-b78f-49c1-8ffc-101f9d8b60d3.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2023 from nse](https://archives.nseindia.com/annual_reports/SME_AR_23536_RELIABLE_2022_2023_05092023181346_09052023190026.zip) |
| from nse | [Financial Year 2022 from nse](https://archives.nseindia.com/annual_reports/SME_AR_21195_RELIABLE_2021_2022_03092022131630_09032022140001.zip) |
| from nse | [Financial Year 2021 from nse](https://archives.nseindia.com/annual_reports/SME_AR_19501_RELIABLE_2020_2021_06092021175642_09062021180018.zip) |
| from nse | [Financial Year 2020 from nse](https://archives.nseindia.com/annual_reports/SME_AR_17523_RELIABLE_2019_2020_07092020171225_07092020180008.zip) |
| from nse | [Financial Year 2019 from nse](https://archives.nseindia.com/annual_reports/SME_AR_16094_RELIABLE_2018_2019_27092019181637_27092019190008.zip) |
| from nse | [Financial Year 2018 from nse](https://archives.nseindia.com/annual_reports/SME_AR_12397_RELIABLE_2017_2018_17062018191424.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9e6da5e9-052b-4861-a814-07495ec391b0.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/deb5e1fb-cf36-480e-aaeb-95f4de63030c.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b85837d1-6c34-4c28-a62c-edad1077c847.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/421b804c-546e-4225-b311-c7002a07f396.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:37:37.411Z.